Ben Wang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Bone Tissue Engineering Materials
- 3D Printing in Biomedical Research
Papers in
-
- Nanoplatforms for cancer theranostics 13
- Bone Tissue Engineering Materials 12
- 3D Printing in Biomedical Research 9
- Co-authors
- Shilpa Sant (2 shared papers)Tapas Sen (1 shared paper)Morteza Mahmoudi (1 shared paper)Sophie Laurent (1 shared paper)Chuanjiang He (4 shared papers)Shu Zheng (2 shared papers)Yan Luo (2 shared papers)Chuck Zhang (19 shared papers)
- Journals
- ACS Nano (6 papers)Nanotechnology (5 papers)Frontiers in Oncology (4 papers)Angewandte Chemie International Edition (4 papers)Theranostics (4 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Ben Wang
233 papers receiving 10.0k citations
Ben Wang's Hit Papers
Peers
Comparison fields: 5 of 178
- Biomaterials 1.9k
- Biomedical Engineering 3.3k
- Rheumatology 915
- Cancer Research 772
- Polymers and Plastics 635
Countries citing papers authored by Ben Wang
This map shows the geographic impact of Ben Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Wang more than expected).
Fields of papers citing papers by Ben Wang
This network shows the impact of papers produced by Ben Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Wang. The network helps show where Ben Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy Hit paper breakdown → | 2010 | 1479 |
| 2 | Exosome Theranostics: Biology and Translational Medicine Hit paper breakdown → | 2017 | 1015 |
| 3 | Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial Hit paper breakdown → | 2004 | 942 |
| 4 | 2004 | 332 | |
| 5 | 2007 | 273 | |
| 6 | 2011 | 265 | |
| 7 | 2008 | 211 | |
| 8 | 2010 | 129 | |
| 9 | 2016 | 120 | |
| 10 | 2020 | 119 | |
| 11 | 2020 | 117 | |
| 12 | 2019 | 115 | |
| 13 | 2020 | 113 | |
| 14 | 2005 | 110 | |
| 15 | 2019 | 101 | |
| 16 | 2019 | 94 | |
| 17 | 2015 | 88 | |
| 18 | 2014 | 87 | |
| 19 | 2014 | 80 | |
| 20 | 2016 | 80 |
About Ben Wang
Ben Wang is a scholar working on Biomedical Engineering, Molecular Biology, Materials Chemistry, Biomaterials and Mechanical Engineering, having authored 243 papers that have together received 10.1k indexed citations. Recurring topics across this work include Carbon Nanotubes in Composites (15 papers), Nanoplatforms for cancer theranostics (13 papers), Bone Tissue Engineering Materials (12 papers), Cell Adhesion Molecules Research (9 papers), 3D Printing in Biomedical Research (9 papers), Tribology and Lubrication Engineering (8 papers), Immunotherapy and Immune Responses (7 papers) and Ferroptosis and cancer prognosis (7 papers). The work is most often cited by research in Biomaterials (1.9k citations), Biomedical Engineering (3.3k citations), Rheumatology (915 citations), Cancer Research (772 citations) and Polymers and Plastics (635 citations). Ben Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shilpa Sant, Tapas Sen, Morteza Mahmoudi, Sophie Laurent, Chuanjiang He, Shu Zheng, Yan Luo, Chuck Zhang, Ruikang Tang and Zhiyong Liang. Their work appears in journals such as ACS Nano, Nanotechnology, Frontiers in Oncology, Angewandte Chemie International Edition and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.